Food and Drug Administration (FDA) has approved enzalutamide (Xtandi) for the treatment of non-metastatic castration-sensitive prostate cancer that has experienced a biochemical recurrence that indicates a high risk of metastasis
The building blocks of a monthly telehealth bill Program fee versus medication cost A telehealth GLP-1 bill generally separates into the program or membership fee and the medication itself
Authors: Karen G Farrar University of Southern California , Los Angeles, CA, Duy Do Truveta, Inc , Bellevue, WA, Nina B Masters Truveta, Inc , Bellevue, WA, Brianna M Cartwright Truveta, Inc , Bellevue, WA After CVS Caremark made anti-obesity semaglutide the preferred formulary option in July 2025, switching from anti-obesity tirzepatide surged from 0.6% to 9.7%, representing more than a 16-fold rise
Your health and well-being are our top priorities
PAP supports uninsured or underinsured individuals who meet income and eligibility criteria